Semi-Annual Consolidated Statement Of Cash Flows

D.Western Therapeutics Institute, Inc. - Filing #7313030

Concept 2024-01-01 to
2024-06-30
As at
2024-06-30
As at
2023-12-31
2023-01-01 to
2023-06-30
As at
2023-06-30
As at
2022-12-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-519,900,000 JPY
-254,590,000 JPY
Depreciation
24,398,000 JPY
23,206,000 JPY
Increase (decrease) in allowance for doubtful accounts
1,535,000 JPY
JPY
Interest expenses
2,103,000 JPY
1,225,000 JPY
Foreign exchange losses (gains)
-1,847,000 JPY
-1,266,000 JPY
Decrease (increase) in trade receivables
-6,172,000 JPY
67,843,000 JPY
Decrease (increase) in inventories
-15,658,000 JPY
-30,463,000 JPY
Other, net
22,715,000 JPY
-638,000 JPY
Subtotal
-787,120,000 JPY
-140,022,000 JPY
Interest paid
-2,084,000 JPY
-1,073,000 JPY
Income taxes paid
-1,594,000 JPY
-1,592,000 JPY
Net cash provided by (used in) operating activities
-790,794,000 JPY
-142,683,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-8,487,000 JPY
-3,428,000 JPY
Net cash provided by (used in) investing activities
-9,587,000 JPY
-3,744,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
170,000,000 JPY
31,000,000 JPY
Proceeds from issuance of bonds
660,000,000 JPY
JPY
Repayments of long-term borrowings
JPY
-60,000,000 JPY
Purchase of treasury shares
JPY
0 JPY
Net cash provided by (used in) financing activities
233,862,000 JPY
46,606,000 JPY
Effect of exchange rate change on cash and cash equivalents
314,000 JPY
256,000 JPY
Net increase (decrease) in cash and cash equivalents
-566,205,000 JPY
-99,563,000 JPY
Cash and cash equivalents
1,301,058,000 JPY
1,867,264,000 JPY
2,235,105,000 JPY
2,334,668,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.